Published in J Virol on February 01, 1984
Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans. J Virol (1985) 2.40
The small subunit of ribonucleotide reductase is encoded by one of the most abundant translationally regulated maternal RNAs in clam and sea urchin eggs. J Cell Biol (1985) 1.68
Herpes simplex virus specifies two subunits of ribonucleotide reductase encoded by 3'-coterminal transcripts. J Virol (1986) 1.39
Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor. J Virol (1990) 1.26
The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection. J Virol (1993) 1.22
Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase. J Virol (1986) 1.18
Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J Virol (1989) 1.17
Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2. J Virol (1989) 1.04
The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J Virol (1998) 0.99
Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase. J Virol (1986) 0.98
DNA amplification and neoplastic transformation mediated by a herpes simplex DNA fragment containing cell-related sequences. Proc Natl Acad Sci U S A (1986) 0.98
Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product. Proc Natl Acad Sci U S A (1985) 0.93
Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease. Antimicrob Agents Chemother (1996) 0.92
Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2. J Virol (1986) 0.82
Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation. Exp Eye Res (2007) 0.77
Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine. PLoS One (2015) 0.76
Identification of viral polypeptides involved in pseudorabies virus ribonucleotide reductase activity. J Virol (1987) 0.75
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect Immun (1981) 7.17
Reduction of ribonucleotides. Annu Rev Biochem (1979) 6.33
Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells. Virology (1975) 5.47
Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci U S A (1980) 3.12
Detailed characterization of the mRNA mapping in the HindIII fragment K region of the herpes simplex virus type 1 genome. J Virol (1981) 3.10
Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species. J Virol (1981) 2.97
Organization of the herpes simplex virus type 1 transcription unit encoding two early proteins with molecular weights of 140000 and 40000. J Gen Virol (1983) 1.90
Detailed characterization of an apparently unspliced beta herpes simplex virus type 1 gene mapping in the interior of another. J Virol (1982) 1.84
Antigenic differences between isolates of herpesvirus type 2. Intervirology (1974) 1.79
Ribonucleotide reductase induced by herpes simplex virus has a virus-specified constituent. J Gen Virol (1983) 1.71
Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells. J Virol (1981) 1.55
Ribonucleotide reductase from herpes simplex virus (types 1 and 2) infected and uninfected KB cells: properties of the partially purified enzymes. J Gen Virol (1977) 1.47
Identification of proteins encoded by a fragment of herpes simplex virus type 2 DNA that has transforming activity. J Virol (1982) 1.42
Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV). J Gen Virol (1981) 1.35
Herpes simplex virus-induced ribonucleotide reductase: development of antibodies specific for the enzyme. J Gen Virol (1983) 1.29
Is ribonucleotide reductase the transforming function of herpes simplex virus 2? Nature (1983) 1.26
Regulation of ribonucleotide reductase. Curr Top Cell Regul (1981) 1.21
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell (1985) 6.88
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc Natl Acad Sci U S A (1977) 4.35
Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A (1994) 3.86
A rapid and efficient procedure for the purification of DNA from agarose gels. Anal Biochem (1980) 3.77
Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol (1993) 3.67
Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet (1999) 3.37
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02
A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet (2000) 2.80
Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol (1994) 2.76
Telomerase activity in normal leukocytes and in hematologic malignancies. Blood (1995) 2.71
The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med (1994) 2.61
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol (1994) 2.57
The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet (1999) 2.52
Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans. J Virol (1985) 2.40
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. J Virol (1982) 2.24
Selective assay for herpes simplex viruses expressing thymidine kinase. J Virol (1979) 2.03
Establishment and chimera analysis of 129/SvEv- and C57BL/6-derived mouse embryonic stem cell lines. Biotechniques (2000) 1.99
The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet (1997) 1.97
Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol (1981) 1.94
The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87
Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res (1996) 1.87
Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer. Proc Natl Acad Sci U S A (1987) 1.86
Herpes simplex virus thymidine kinase transcripts are absent from both nucleus and cytoplasm during infection in the presence of cycloheximide. J Virol (1980) 1.86
B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J (1993) 1.82
Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 1.69
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A (1998) 1.67
Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology (1991) 1.66
Mapping of a 14,000-dalton antigen to early region 4 of the human adenovirus 5 genome. J Virol (1983) 1.64
Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem (1999) 1.64
Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol (2000) 1.60
Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst (1996) 1.57
Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells. J Virol (1981) 1.55
Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J (1996) 1.54
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J Biol Chem (2000) 1.49
Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J Gen Virol (1990) 1.48
Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet (2001) 1.48
Tn5 mutagenesis of the transforming genes of human adenovirus type 5. Gene (1983) 1.41
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer (2010) 1.39
Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol (1997) 1.38
Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci U S A (1996) 1.37
Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol (1995) 1.35
Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol (1997) 1.34
Telomerase activity in normal and malignant murine tissues. Oncogene (1995) 1.34
Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer (1998) 1.34
Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene (2001) 1.31
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29
Herpes simplex virus-induced ribonucleotide reductase: development of antibodies specific for the enzyme. J Gen Virol (1983) 1.29
A UV-specific endonucleolytic activity present in human cell extracts. Biochem Biophys Res Commun (1972) 1.29
Is ribonucleotide reductase the transforming function of herpes simplex virus 2? Nature (1983) 1.26
Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology (1989) 1.23
Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2. J Virol Methods (1981) 1.22
Integration and expression of viral DNA in cells transformed by host range mutants of adenovirus type 5. J Virol (1982) 1.20
Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase. J Virol (1986) 1.18
Covalently closed circles of adenovirus 5 DNA. Nature (1983) 1.17
Genetic interactions between error-prone and error-free postreplication repair pathways in Saccharomyces cerevisiae. Mutat Res (1999) 1.16
Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci U S A (1999) 1.13
Purification and characterization of an endonuclease from calf thymus acting on irradiated DNA. Biochim Biophys Acta (1975) 1.13
Actinomycin D: effects on mouse L-cells. Biophys J (1969) 1.13
The mahogany protein is a receptor involved in suppression of obesity. Nature (1999) 1.12
The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J Immunol (1994) 1.11
Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation. Mol Cell Biol (2000) 1.09
The relation of protein synthesis to radiation-induced division delay in Chinese hamster cells. Radiat Res (1970) 1.09
Insertion of a bacterial gene into the mouse germ line using an infectious retrovirus vector. Proc Natl Acad Sci U S A (1985) 1.09
Phenotypic rescue of mutant brown melanocytes by a retrovirus carrying a wild-type tyrosinase-related protein gene. Development (1990) 1.09
Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg (2001) 1.09
Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells. J Gen Virol (1990) 1.03
Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5. J Virol (1984) 0.98
Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum Mol Genet (1998) 0.97
High frequency recombination between loxP sites in human chromosomes mediated by an adenovirus vector expressing Cre recombinase. Somat Cell Mol Genet (1995) 0.97
Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology (1988) 0.96
Relation of Herpes simplex viruses to human malignancies. Curr Top Microbiol Immunol (1977) 0.96
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis (2002) 0.95
Telomeres and telomerase in human cancer (review). Int J Oncol (1995) 0.95
Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Arch Virol (1987) 0.95
Effects of mutations at the W locus (c-kit) on inner ear pigmentation and function in the mouse. Pigment Cell Res (1994) 0.94
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Gene Ther (2003) 0.94
Human antibodies from transgenic mice. Int Rev Immunol (1995) 0.92
Construction of a recombinant adenovirus for efficient delivery of the I-SceI yeast endonuclease to human cells and its application in the in vivo cleavage of chromosomes to expose new potential telomeres. Nucleic Acids Res (1999) 0.92
Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma. Int J Cancer (1985) 0.92
Quantitative analysis of regions of adenovirus E1A products involved in interactions with cellular proteins. Biochem Cell Biol (1993) 0.91
Chromosomal damage induced by human adenovirus type 12 requires expression of the E1B 55-kilodalton viral protein. J Virol (1990) 0.91
Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Oncogene (1998) 0.87
Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53. Oncogene (1994) 0.87
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM. Int Immunol (1994) 0.86
Transformation by human adenoviruses. J Cell Physiol Suppl (1984) 0.86
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia. Invest New Drugs (2011) 0.85
Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome. Mol Cell Biol (1993) 0.85
Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer (1994) 0.84